FebriTick: Study of Febrile Syndromes After Tick Bite

Sponsor
University Hospital, Strasbourg, France (Other)
Overall Status
Recruiting
CT.gov ID
NCT05090969
Collaborator
(none)
940
1
13
72.3

Study Details

Study Description

Brief Summary

Febrile syndromes after tick bites can be caused by different microorganisms: bacteria (B. miyamotoi, A. phagocytophilum, R. helvetica…), parasites (Babesia spp) and viruses (TBE virus). The clinical picture is not specific but complications may appear depending on the microorganism identified (thrombosis with N. mikurensis, meningoencephalitis with B. miyamotoi and the TBE virus). Thus, in order to provide appropriate treatment and monitoring, the infection should be documented.

Condition or Disease Intervention/Treatment Phase

    Study Design

    Study Type:
    Observational
    Anticipated Enrollment :
    940 participants
    Observational Model:
    Case-Only
    Time Perspective:
    Retrospective
    Official Title:
    Study of Febrile Syndromes After Tick Bite
    Actual Study Start Date :
    Nov 30, 2020
    Anticipated Primary Completion Date :
    Dec 31, 2021
    Anticipated Study Completion Date :
    Dec 31, 2021

    Outcome Measures

    Primary Outcome Measures

    1. Retrospective search for the presence of an emerging pathogen in the cohort of patients with febrile syndrome after tick bite [Files analysed retrospectively from January 01, 2009 to August 31, 2020 will be examined]]

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years and Older
    Sexes Eligible for Study:
    All
    Inclusion criteria:
    • Major subject (≥18 years old)

    • Subject whose sample was sent to the bacteriology laboratory for research on Anaplasma phagocytophilum between 2009 and August 2020

    Exclusion criteria:
    • Subject having expressed his opposition to his medical data and biological resources not being reused for scientific research.

    • Subject under guardianship or guardianship

    • Subject under safeguard of justice

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Service Laboratoire de Bactériologie - Hôpitaux Universitaires de Strasbourg Strasbourg France 67091

    Sponsors and Collaborators

    • University Hospital, Strasbourg, France

    Investigators

    • Principal Investigator: Benoit JAULHAC, MD, PhD, Service Laboratoire de Bactériologie - Hôpitaux Universitaires de Strasbourg
    • Principal Investigator: Pierre BOYER, MD, Service Laboratoire de Bactériologie - Hôpitaux Universitaires de Strasbourg

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    University Hospital, Strasbourg, France
    ClinicalTrials.gov Identifier:
    NCT05090969
    Other Study ID Numbers:
    • 7992
    First Posted:
    Oct 25, 2021
    Last Update Posted:
    Dec 1, 2021
    Last Verified:
    Oct 1, 2021
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by University Hospital, Strasbourg, France
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Dec 1, 2021